Sort
48,018 grants matching “immunotherapy”
Investigating the therapeutic potential of a novel glutamine antagonist in KEAP1 mutant lung cancer
$655,478Thales Papagiannakopoulos · New York University School Of Medicine · R01 · FY2025 · CA
Proteolysis targeting chimera against nuclear receptor NR4A1 for melanoma therapy
$655,441Weizhou Zhang · University Of Florida · R01 · FY2025 · CA
Immunotherapeutics Against Other Filovirus Threats
$655,426Jonathan R. Lai · Scripps Research Institute, The · U19 · FY2015 · AI
A Chemical Genetic Approach to Exploring Novel Therapeutic Space for Colorectal Cancer
$655,407Arvin Dar · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Manipulating microenvironment and vasculature to enhance T cell infiltration into tumors
$655,260Victor H. Engelhard · University Of Virginia · R01 · FY2021 · CA
Regulatory T Cells and Pulmonary Hypertension
$655,254Mark Robert Nicolls · Palo Alto Veterans Instit For Research · R01 · FY2021 · HL
UBR5's mechanisms of action in tumorigenesis and immunoregulation
$655,228Xiaojing Ma · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
UBR5's mechanisms of action in tumorigenesis and immunoregulation
$655,228Xiaojing Ma · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA
A Type I Hybrid Effectiveness-Implementation Trial to Evaluate a Navigation-Based Multilevel Intervention to Decrease Delays Starting Adjuvant Therapy Among Patients with Head and Neck Cancer
$655,170Evan Michael Graboyes · Medical University Of South Carolina · R01 · FY2024 · CA
Core C: Clinical Management and Resources
$655,148Igor Puzanov · Roswell Park Cancer Institute Corp · P01 · FY2023 · CA
Tuning KITv CAR T cells for the solid tumor environment
$655,042Prasad S. Adusumilli · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Personal tumor neoantigens for immunity against chronic lymphocytic leukemia
$655,040Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2019 · CA
CHARACTERIZING IMMUNOLOGICAL AND GENOMIC RESISTANCE MECHANISMS TO ANTI-PD-1 IMMUNOTHERAPY IN SMOKING-ASSOCIATED HEAD AND NECK CANCER
$655,000The Feinstein Institutes For Medical Research · · FY2022 · Defense Health Agency
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
$654,974Joseph John Barchi · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Tissue ProcessingSequencing Facility
$654,952Cathy D Vocke · Division Of Basic Sciences - Nci · ZIC · FY2015 · CA
Investigating the Role of VISTA in Driving Immune Evasion in Acute Myeloid Leukemia
$654,837Li Lily Wang · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · CA
Defining the Mechanistic Basis of Bacterial Androgen Production in Dampening Anti-Tumor Immunity and Promoting Resistance to Androgen Receptor Axis-Targeted Therapies for Metastatic Prostate Cancer
$654,763Karen Sandell Sfanos · Johns Hopkins University · R01 · FY2024 · CA
Immunology of aging and immunotherapy of aging-associated diseases
$654,739Bira Arya · National Institute On Aging · ZIA · FY2016 · AG
Project 1: Clinical and immune impact of radiation and dual checkpoint blockade in patients
$654,726Robert H Vonderheide · University Of Pennsylvania · P01 · FY2017 · CA
Project 1: Clinical and immune impact of radiation and dual checkpoint blockade in patients
$654,726Robert H Vonderheide · University Of Pennsylvania · P01 · FY2018 · CA
Memory, Phenotype, and Function of TB-reactive Human MR1 Restricted T cells
$654,713David M. Lewinsohn · Oregon Health & Science University · R01 · FY2019 · AI
Development of Non-Catalytic Peptide Inhibitors of Focal Adhesion Kinase (FAK) for Use in Melanoma
$654,706Timothy A Marlowe · Faknostics, Llc · R42 · FY2023 · CA
Anticancer ELNP nanovaccines for curative treatmentof pancreatic cancer
$654,681Zheng-Rong Lu · Case Western Reserve University · R01 · FY2025 · CA
Image-based models of tumor-immune dynamics in glioblastoma
$654,652Kristin R Swanson · Mayo Clinic Arizona · U01 · FY2023 · CA
Engineered Nano-formulations for STING Activation
$654,648James J. Moon · University Of Michigan At Ann Arbor · R01 · FY2025 · DE